Answers are grounded in this paper and cite their sources.
Clinical entity identified differentiates mild cognitive impairment from healthy controls and very mild AD, suggesting targeted treatments.
Patients who meet the criteria for MCI can be differentiated from healthy control subjects and those with very mild AD. They appear to constitute a clinical entity that can be characterized for treatment interventions.
No takes yet. Share an insight, caveat, or question.
Petersen et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: